Favorable outcome with sentinel lymph node biopsy alone after neoadjuvant chemotherapy in clinically node positive breast cancer at diagnosis: Turkish Multicentric NEOSENTI-TURK MF-18-02-study
Factors affecting local outcome were evaluated in patients with clinically node-positive (cN+) breast cancer at diagnosis, who underwent sentinel lymph node biopsy (SLNB) alone after neoadjuvant chemotherapy (NAC).
Gespeichert in:
| Autor*in: |
Cabıoğlu, N. [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2021 |
|---|
| Schlagwörter: |
|---|
| Umfang: |
9 |
|---|
| Übergeordnetes Werk: |
Enthalten in: Updated insight into the role of Th2-associated immunity in systemic lupus erythematosus - Wang, Hui ELSEVIER, 2022, Burlington, Mass |
|---|---|
| Übergeordnetes Werk: |
volume:47 ; year:2021 ; number:10 ; pages:2506-2514 ; extent:9 |
| Links: |
|---|
| DOI / URN: |
10.1016/j.ejso.2021.06.024 |
|---|
| Katalog-ID: |
ELV055428975 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV055428975 | ||
| 003 | DE-627 | ||
| 005 | 20230624221551.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 220105s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.ejso.2021.06.024 |2 doi | |
| 028 | 5 | 2 | |a /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001513.pica |
| 035 | |a (DE-627)ELV055428975 | ||
| 035 | |a (ELSEVIER)S0748-7983(21)00587-4 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |q VZ |
| 084 | |a 44.45 |2 bkl | ||
| 100 | 1 | |a Cabıoğlu, N. |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Favorable outcome with sentinel lymph node biopsy alone after neoadjuvant chemotherapy in clinically node positive breast cancer at diagnosis: Turkish Multicentric NEOSENTI-TURK MF-18-02-study |
| 264 | 1 | |c 2021 | |
| 300 | |a 9 | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a Factors affecting local outcome were evaluated in patients with clinically node-positive (cN+) breast cancer at diagnosis, who underwent sentinel lymph node biopsy (SLNB) alone after neoadjuvant chemotherapy (NAC). | ||
| 650 | 7 | |a Neoadjuvant chemotherapy |2 Elsevier | |
| 650 | 7 | |a Isolated tumor cells |2 Elsevier | |
| 650 | 7 | |a Local recurrence |2 Elsevier | |
| 650 | 7 | |a Sentinel lymph node biopsy |2 Elsevier | |
| 650 | 7 | |a Pathologic complete response |2 Elsevier | |
| 650 | 7 | |a Micrometastasis |2 Elsevier | |
| 700 | 1 | |a Karanlık, H. |4 oth | |
| 700 | 1 | |a Yıldırım, N. |4 oth | |
| 700 | 1 | |a Müslümanoğlu, M. |4 oth | |
| 700 | 1 | |a Çakmak Karadeniz, G. |4 oth | |
| 700 | 1 | |a Trabulus Can, D. |4 oth | |
| 700 | 1 | |a Tükenmez, M. |4 oth | |
| 700 | 1 | |a Ersoy, Y.E. |4 oth | |
| 700 | 1 | |a Uras, C. |4 oth | |
| 700 | 1 | |a Zengel, B. |4 oth | |
| 700 | 1 | |a Emiroğlu, S. |4 oth | |
| 700 | 1 | |a Polat, A.K. |4 oth | |
| 700 | 1 | |a Yeniay, L. |4 oth | |
| 700 | 1 | |a Özkurt, E. |4 oth | |
| 700 | 1 | |a Kara, H. |4 oth | |
| 700 | 1 | |a İbiş, K. |4 oth | |
| 700 | 1 | |a Aydıner, A. |4 oth | |
| 700 | 1 | |a Özmen, V. |4 oth | |
| 700 | 1 | |a İğci, A. |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Harcourt |a Wang, Hui ELSEVIER |t Updated insight into the role of Th2-associated immunity in systemic lupus erythematosus |d 2022 |g Burlington, Mass |w (DE-627)ELV008984085 |
| 773 | 1 | 8 | |g volume:47 |g year:2021 |g number:10 |g pages:2506-2514 |g extent:9 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.ejso.2021.06.024 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 912 | |a SSG-OLC-PHA | ||
| 936 | b | k | |a 44.45 |j Immunologie |q VZ |
| 951 | |a AR | ||
| 952 | |d 47 |j 2021 |e 10 |h 2506-2514 |g 9 | ||
| author_variant |
n c nc |
|---|---|
| matchkey_str |
cabolunkaranlkhyldrmnmslmanolumakmakkara:2021----:aoalotoeihetnlypndbosaoefenoduathmteaynlnclyoeoiieratacrtigoi |
| hierarchy_sort_str |
2021 |
| bklnumber |
44.45 |
| publishDate |
2021 |
| allfields |
10.1016/j.ejso.2021.06.024 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001513.pica (DE-627)ELV055428975 (ELSEVIER)S0748-7983(21)00587-4 DE-627 ger DE-627 rakwb eng 610 VZ 44.45 bkl Cabıoğlu, N. verfasserin aut Favorable outcome with sentinel lymph node biopsy alone after neoadjuvant chemotherapy in clinically node positive breast cancer at diagnosis: Turkish Multicentric NEOSENTI-TURK MF-18-02-study 2021 9 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Factors affecting local outcome were evaluated in patients with clinically node-positive (cN+) breast cancer at diagnosis, who underwent sentinel lymph node biopsy (SLNB) alone after neoadjuvant chemotherapy (NAC). Neoadjuvant chemotherapy Elsevier Isolated tumor cells Elsevier Local recurrence Elsevier Sentinel lymph node biopsy Elsevier Pathologic complete response Elsevier Micrometastasis Elsevier Karanlık, H. oth Yıldırım, N. oth Müslümanoğlu, M. oth Çakmak Karadeniz, G. oth Trabulus Can, D. oth Tükenmez, M. oth Ersoy, Y.E. oth Uras, C. oth Zengel, B. oth Emiroğlu, S. oth Polat, A.K. oth Yeniay, L. oth Özkurt, E. oth Kara, H. oth İbiş, K. oth Aydıner, A. oth Özmen, V. oth İğci, A. oth Enthalten in Harcourt Wang, Hui ELSEVIER Updated insight into the role of Th2-associated immunity in systemic lupus erythematosus 2022 Burlington, Mass (DE-627)ELV008984085 volume:47 year:2021 number:10 pages:2506-2514 extent:9 https://doi.org/10.1016/j.ejso.2021.06.024 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.45 Immunologie VZ AR 47 2021 10 2506-2514 9 |
| spelling |
10.1016/j.ejso.2021.06.024 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001513.pica (DE-627)ELV055428975 (ELSEVIER)S0748-7983(21)00587-4 DE-627 ger DE-627 rakwb eng 610 VZ 44.45 bkl Cabıoğlu, N. verfasserin aut Favorable outcome with sentinel lymph node biopsy alone after neoadjuvant chemotherapy in clinically node positive breast cancer at diagnosis: Turkish Multicentric NEOSENTI-TURK MF-18-02-study 2021 9 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Factors affecting local outcome were evaluated in patients with clinically node-positive (cN+) breast cancer at diagnosis, who underwent sentinel lymph node biopsy (SLNB) alone after neoadjuvant chemotherapy (NAC). Neoadjuvant chemotherapy Elsevier Isolated tumor cells Elsevier Local recurrence Elsevier Sentinel lymph node biopsy Elsevier Pathologic complete response Elsevier Micrometastasis Elsevier Karanlık, H. oth Yıldırım, N. oth Müslümanoğlu, M. oth Çakmak Karadeniz, G. oth Trabulus Can, D. oth Tükenmez, M. oth Ersoy, Y.E. oth Uras, C. oth Zengel, B. oth Emiroğlu, S. oth Polat, A.K. oth Yeniay, L. oth Özkurt, E. oth Kara, H. oth İbiş, K. oth Aydıner, A. oth Özmen, V. oth İğci, A. oth Enthalten in Harcourt Wang, Hui ELSEVIER Updated insight into the role of Th2-associated immunity in systemic lupus erythematosus 2022 Burlington, Mass (DE-627)ELV008984085 volume:47 year:2021 number:10 pages:2506-2514 extent:9 https://doi.org/10.1016/j.ejso.2021.06.024 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.45 Immunologie VZ AR 47 2021 10 2506-2514 9 |
| allfields_unstemmed |
10.1016/j.ejso.2021.06.024 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001513.pica (DE-627)ELV055428975 (ELSEVIER)S0748-7983(21)00587-4 DE-627 ger DE-627 rakwb eng 610 VZ 44.45 bkl Cabıoğlu, N. verfasserin aut Favorable outcome with sentinel lymph node biopsy alone after neoadjuvant chemotherapy in clinically node positive breast cancer at diagnosis: Turkish Multicentric NEOSENTI-TURK MF-18-02-study 2021 9 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Factors affecting local outcome were evaluated in patients with clinically node-positive (cN+) breast cancer at diagnosis, who underwent sentinel lymph node biopsy (SLNB) alone after neoadjuvant chemotherapy (NAC). Neoadjuvant chemotherapy Elsevier Isolated tumor cells Elsevier Local recurrence Elsevier Sentinel lymph node biopsy Elsevier Pathologic complete response Elsevier Micrometastasis Elsevier Karanlık, H. oth Yıldırım, N. oth Müslümanoğlu, M. oth Çakmak Karadeniz, G. oth Trabulus Can, D. oth Tükenmez, M. oth Ersoy, Y.E. oth Uras, C. oth Zengel, B. oth Emiroğlu, S. oth Polat, A.K. oth Yeniay, L. oth Özkurt, E. oth Kara, H. oth İbiş, K. oth Aydıner, A. oth Özmen, V. oth İğci, A. oth Enthalten in Harcourt Wang, Hui ELSEVIER Updated insight into the role of Th2-associated immunity in systemic lupus erythematosus 2022 Burlington, Mass (DE-627)ELV008984085 volume:47 year:2021 number:10 pages:2506-2514 extent:9 https://doi.org/10.1016/j.ejso.2021.06.024 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.45 Immunologie VZ AR 47 2021 10 2506-2514 9 |
| allfieldsGer |
10.1016/j.ejso.2021.06.024 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001513.pica (DE-627)ELV055428975 (ELSEVIER)S0748-7983(21)00587-4 DE-627 ger DE-627 rakwb eng 610 VZ 44.45 bkl Cabıoğlu, N. verfasserin aut Favorable outcome with sentinel lymph node biopsy alone after neoadjuvant chemotherapy in clinically node positive breast cancer at diagnosis: Turkish Multicentric NEOSENTI-TURK MF-18-02-study 2021 9 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Factors affecting local outcome were evaluated in patients with clinically node-positive (cN+) breast cancer at diagnosis, who underwent sentinel lymph node biopsy (SLNB) alone after neoadjuvant chemotherapy (NAC). Neoadjuvant chemotherapy Elsevier Isolated tumor cells Elsevier Local recurrence Elsevier Sentinel lymph node biopsy Elsevier Pathologic complete response Elsevier Micrometastasis Elsevier Karanlık, H. oth Yıldırım, N. oth Müslümanoğlu, M. oth Çakmak Karadeniz, G. oth Trabulus Can, D. oth Tükenmez, M. oth Ersoy, Y.E. oth Uras, C. oth Zengel, B. oth Emiroğlu, S. oth Polat, A.K. oth Yeniay, L. oth Özkurt, E. oth Kara, H. oth İbiş, K. oth Aydıner, A. oth Özmen, V. oth İğci, A. oth Enthalten in Harcourt Wang, Hui ELSEVIER Updated insight into the role of Th2-associated immunity in systemic lupus erythematosus 2022 Burlington, Mass (DE-627)ELV008984085 volume:47 year:2021 number:10 pages:2506-2514 extent:9 https://doi.org/10.1016/j.ejso.2021.06.024 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.45 Immunologie VZ AR 47 2021 10 2506-2514 9 |
| allfieldsSound |
10.1016/j.ejso.2021.06.024 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001513.pica (DE-627)ELV055428975 (ELSEVIER)S0748-7983(21)00587-4 DE-627 ger DE-627 rakwb eng 610 VZ 44.45 bkl Cabıoğlu, N. verfasserin aut Favorable outcome with sentinel lymph node biopsy alone after neoadjuvant chemotherapy in clinically node positive breast cancer at diagnosis: Turkish Multicentric NEOSENTI-TURK MF-18-02-study 2021 9 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Factors affecting local outcome were evaluated in patients with clinically node-positive (cN+) breast cancer at diagnosis, who underwent sentinel lymph node biopsy (SLNB) alone after neoadjuvant chemotherapy (NAC). Neoadjuvant chemotherapy Elsevier Isolated tumor cells Elsevier Local recurrence Elsevier Sentinel lymph node biopsy Elsevier Pathologic complete response Elsevier Micrometastasis Elsevier Karanlık, H. oth Yıldırım, N. oth Müslümanoğlu, M. oth Çakmak Karadeniz, G. oth Trabulus Can, D. oth Tükenmez, M. oth Ersoy, Y.E. oth Uras, C. oth Zengel, B. oth Emiroğlu, S. oth Polat, A.K. oth Yeniay, L. oth Özkurt, E. oth Kara, H. oth İbiş, K. oth Aydıner, A. oth Özmen, V. oth İğci, A. oth Enthalten in Harcourt Wang, Hui ELSEVIER Updated insight into the role of Th2-associated immunity in systemic lupus erythematosus 2022 Burlington, Mass (DE-627)ELV008984085 volume:47 year:2021 number:10 pages:2506-2514 extent:9 https://doi.org/10.1016/j.ejso.2021.06.024 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.45 Immunologie VZ AR 47 2021 10 2506-2514 9 |
| language |
English |
| source |
Enthalten in Updated insight into the role of Th2-associated immunity in systemic lupus erythematosus Burlington, Mass volume:47 year:2021 number:10 pages:2506-2514 extent:9 |
| sourceStr |
Enthalten in Updated insight into the role of Th2-associated immunity in systemic lupus erythematosus Burlington, Mass volume:47 year:2021 number:10 pages:2506-2514 extent:9 |
| format_phy_str_mv |
Article |
| bklname |
Immunologie |
| institution |
findex.gbv.de |
| topic_facet |
Neoadjuvant chemotherapy Isolated tumor cells Local recurrence Sentinel lymph node biopsy Pathologic complete response Micrometastasis |
| dewey-raw |
610 |
| isfreeaccess_bool |
false |
| container_title |
Updated insight into the role of Th2-associated immunity in systemic lupus erythematosus |
| authorswithroles_txt_mv |
Cabıoğlu, N. @@aut@@ Karanlık, H. @@oth@@ Yıldırım, N. @@oth@@ Müslümanoğlu, M. @@oth@@ Çakmak Karadeniz, G. @@oth@@ Trabulus Can, D. @@oth@@ Tükenmez, M. @@oth@@ Ersoy, Y.E. @@oth@@ Uras, C. @@oth@@ Zengel, B. @@oth@@ Emiroğlu, S. @@oth@@ Polat, A.K. @@oth@@ Yeniay, L. @@oth@@ Özkurt, E. @@oth@@ Kara, H. @@oth@@ İbiş, K. @@oth@@ Aydıner, A. @@oth@@ Özmen, V. @@oth@@ İğci, A. @@oth@@ |
| publishDateDaySort_date |
2021-01-01T00:00:00Z |
| hierarchy_top_id |
ELV008984085 |
| dewey-sort |
3610 |
| id |
ELV055428975 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV055428975</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624221551.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">220105s2021 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.ejso.2021.06.024</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">/cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001513.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV055428975</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0748-7983(21)00587-4</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.45</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Cabıoğlu, N.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Favorable outcome with sentinel lymph node biopsy alone after neoadjuvant chemotherapy in clinically node positive breast cancer at diagnosis: Turkish Multicentric NEOSENTI-TURK MF-18-02-study</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2021</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">9</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Factors affecting local outcome were evaluated in patients with clinically node-positive (cN+) breast cancer at diagnosis, who underwent sentinel lymph node biopsy (SLNB) alone after neoadjuvant chemotherapy (NAC).</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Neoadjuvant chemotherapy</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Isolated tumor cells</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Local recurrence</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Sentinel lymph node biopsy</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Pathologic complete response</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Micrometastasis</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Karanlık, H.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Yıldırım, N.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Müslümanoğlu, M.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Çakmak Karadeniz, G.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Trabulus Can, D.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Tükenmez, M.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ersoy, Y.E.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Uras, C.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Zengel, B.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Emiroğlu, S.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Polat, A.K.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Yeniay, L.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Özkurt, E.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kara, H.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">İbiş, K.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Aydıner, A.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Özmen, V.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">İğci, A.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Harcourt</subfield><subfield code="a">Wang, Hui ELSEVIER</subfield><subfield code="t">Updated insight into the role of Th2-associated immunity in systemic lupus erythematosus</subfield><subfield code="d">2022</subfield><subfield code="g">Burlington, Mass</subfield><subfield code="w">(DE-627)ELV008984085</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:47</subfield><subfield code="g">year:2021</subfield><subfield code="g">number:10</subfield><subfield code="g">pages:2506-2514</subfield><subfield code="g">extent:9</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.ejso.2021.06.024</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.45</subfield><subfield code="j">Immunologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">47</subfield><subfield code="j">2021</subfield><subfield code="e">10</subfield><subfield code="h">2506-2514</subfield><subfield code="g">9</subfield></datafield></record></collection>
|
| author |
Cabıoğlu, N. |
| spellingShingle |
Cabıoğlu, N. ddc 610 bkl 44.45 Elsevier Neoadjuvant chemotherapy Elsevier Isolated tumor cells Elsevier Local recurrence Elsevier Sentinel lymph node biopsy Elsevier Pathologic complete response Elsevier Micrometastasis Favorable outcome with sentinel lymph node biopsy alone after neoadjuvant chemotherapy in clinically node positive breast cancer at diagnosis: Turkish Multicentric NEOSENTI-TURK MF-18-02-study |
| authorStr |
Cabıoğlu, N. |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV008984085 |
| format |
electronic Article |
| dewey-ones |
610 - Medicine & health |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
610 VZ 44.45 bkl Favorable outcome with sentinel lymph node biopsy alone after neoadjuvant chemotherapy in clinically node positive breast cancer at diagnosis: Turkish Multicentric NEOSENTI-TURK MF-18-02-study Neoadjuvant chemotherapy Elsevier Isolated tumor cells Elsevier Local recurrence Elsevier Sentinel lymph node biopsy Elsevier Pathologic complete response Elsevier Micrometastasis Elsevier |
| topic |
ddc 610 bkl 44.45 Elsevier Neoadjuvant chemotherapy Elsevier Isolated tumor cells Elsevier Local recurrence Elsevier Sentinel lymph node biopsy Elsevier Pathologic complete response Elsevier Micrometastasis |
| topic_unstemmed |
ddc 610 bkl 44.45 Elsevier Neoadjuvant chemotherapy Elsevier Isolated tumor cells Elsevier Local recurrence Elsevier Sentinel lymph node biopsy Elsevier Pathologic complete response Elsevier Micrometastasis |
| topic_browse |
ddc 610 bkl 44.45 Elsevier Neoadjuvant chemotherapy Elsevier Isolated tumor cells Elsevier Local recurrence Elsevier Sentinel lymph node biopsy Elsevier Pathologic complete response Elsevier Micrometastasis |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
h k hk n y ny m m mm k g ç kg kgç c d t cd cdt m t mt y e ye c u cu b z bz s e se a p ap l y ly e ö eö h k hk k i ki a a aa v ö vö a i ai |
| hierarchy_parent_title |
Updated insight into the role of Th2-associated immunity in systemic lupus erythematosus |
| hierarchy_parent_id |
ELV008984085 |
| dewey-tens |
610 - Medicine & health |
| hierarchy_top_title |
Updated insight into the role of Th2-associated immunity in systemic lupus erythematosus |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV008984085 |
| title |
Favorable outcome with sentinel lymph node biopsy alone after neoadjuvant chemotherapy in clinically node positive breast cancer at diagnosis: Turkish Multicentric NEOSENTI-TURK MF-18-02-study |
| ctrlnum |
(DE-627)ELV055428975 (ELSEVIER)S0748-7983(21)00587-4 |
| title_full |
Favorable outcome with sentinel lymph node biopsy alone after neoadjuvant chemotherapy in clinically node positive breast cancer at diagnosis: Turkish Multicentric NEOSENTI-TURK MF-18-02-study |
| author_sort |
Cabıoğlu, N. |
| journal |
Updated insight into the role of Th2-associated immunity in systemic lupus erythematosus |
| journalStr |
Updated insight into the role of Th2-associated immunity in systemic lupus erythematosus |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
600 - Technology |
| recordtype |
marc |
| publishDateSort |
2021 |
| contenttype_str_mv |
zzz |
| container_start_page |
2506 |
| author_browse |
Cabıoğlu, N. |
| container_volume |
47 |
| physical |
9 |
| class |
610 VZ 44.45 bkl |
| format_se |
Elektronische Aufsätze |
| author-letter |
Cabıoğlu, N. |
| doi_str_mv |
10.1016/j.ejso.2021.06.024 |
| dewey-full |
610 |
| title_sort |
favorable outcome with sentinel lymph node biopsy alone after neoadjuvant chemotherapy in clinically node positive breast cancer at diagnosis: turkish multicentric neosenti-turk mf-18-02-study |
| title_auth |
Favorable outcome with sentinel lymph node biopsy alone after neoadjuvant chemotherapy in clinically node positive breast cancer at diagnosis: Turkish Multicentric NEOSENTI-TURK MF-18-02-study |
| abstract |
Factors affecting local outcome were evaluated in patients with clinically node-positive (cN+) breast cancer at diagnosis, who underwent sentinel lymph node biopsy (SLNB) alone after neoadjuvant chemotherapy (NAC). |
| abstractGer |
Factors affecting local outcome were evaluated in patients with clinically node-positive (cN+) breast cancer at diagnosis, who underwent sentinel lymph node biopsy (SLNB) alone after neoadjuvant chemotherapy (NAC). |
| abstract_unstemmed |
Factors affecting local outcome were evaluated in patients with clinically node-positive (cN+) breast cancer at diagnosis, who underwent sentinel lymph node biopsy (SLNB) alone after neoadjuvant chemotherapy (NAC). |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA |
| container_issue |
10 |
| title_short |
Favorable outcome with sentinel lymph node biopsy alone after neoadjuvant chemotherapy in clinically node positive breast cancer at diagnosis: Turkish Multicentric NEOSENTI-TURK MF-18-02-study |
| url |
https://doi.org/10.1016/j.ejso.2021.06.024 |
| remote_bool |
true |
| author2 |
Karanlık, H. Yıldırım, N. Müslümanoğlu, M. Çakmak Karadeniz, G. Trabulus Can, D. Tükenmez, M. Ersoy, Y.E. Uras, C. Zengel, B. Emiroğlu, S. Polat, A.K. Yeniay, L. Özkurt, E. Kara, H. İbiş, K. Aydıner, A. Özmen, V. İğci, A. |
| author2Str |
Karanlık, H. Yıldırım, N. Müslümanoğlu, M. Çakmak Karadeniz, G. Trabulus Can, D. Tükenmez, M. Ersoy, Y.E. Uras, C. Zengel, B. Emiroğlu, S. Polat, A.K. Yeniay, L. Özkurt, E. Kara, H. İbiş, K. Aydıner, A. Özmen, V. İğci, A. |
| ppnlink |
ELV008984085 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth oth oth oth oth oth oth oth oth oth oth oth oth oth oth oth oth |
| doi_str |
10.1016/j.ejso.2021.06.024 |
| up_date |
2024-07-06T17:31:44.342Z |
| _version_ |
1803851770724614144 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV055428975</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624221551.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">220105s2021 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.ejso.2021.06.024</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">/cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001513.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV055428975</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0748-7983(21)00587-4</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.45</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Cabıoğlu, N.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Favorable outcome with sentinel lymph node biopsy alone after neoadjuvant chemotherapy in clinically node positive breast cancer at diagnosis: Turkish Multicentric NEOSENTI-TURK MF-18-02-study</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2021</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">9</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Factors affecting local outcome were evaluated in patients with clinically node-positive (cN+) breast cancer at diagnosis, who underwent sentinel lymph node biopsy (SLNB) alone after neoadjuvant chemotherapy (NAC).</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Neoadjuvant chemotherapy</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Isolated tumor cells</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Local recurrence</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Sentinel lymph node biopsy</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Pathologic complete response</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Micrometastasis</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Karanlık, H.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Yıldırım, N.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Müslümanoğlu, M.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Çakmak Karadeniz, G.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Trabulus Can, D.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Tükenmez, M.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ersoy, Y.E.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Uras, C.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Zengel, B.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Emiroğlu, S.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Polat, A.K.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Yeniay, L.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Özkurt, E.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kara, H.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">İbiş, K.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Aydıner, A.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Özmen, V.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">İğci, A.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Harcourt</subfield><subfield code="a">Wang, Hui ELSEVIER</subfield><subfield code="t">Updated insight into the role of Th2-associated immunity in systemic lupus erythematosus</subfield><subfield code="d">2022</subfield><subfield code="g">Burlington, Mass</subfield><subfield code="w">(DE-627)ELV008984085</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:47</subfield><subfield code="g">year:2021</subfield><subfield code="g">number:10</subfield><subfield code="g">pages:2506-2514</subfield><subfield code="g">extent:9</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.ejso.2021.06.024</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.45</subfield><subfield code="j">Immunologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">47</subfield><subfield code="j">2021</subfield><subfield code="e">10</subfield><subfield code="h">2506-2514</subfield><subfield code="g">9</subfield></datafield></record></collection>
|
| score |
7.4005337 |